PRINS RICHARD K sold $162K of AMPH
PRINS RICHARD K sold 7,973 shares of Amphastar Pharmaceuticals, Inc. (AMPH) at $20.30 ($0.16M total) on 2026-08-11.
How this was made
The 30-second read
Why it matters
The disclosure updates insider activity records but does not provide new information about Amphastar’s business, guidance, or regulatory status.
Market read
Traders may monitor for follow-on insider activity, but this specific sale is unlikely to drive a material repricing without additional company news.
What to watch
No 10b5-1 plan is indicated, so traders may scrutinize timing, but the article provides no reason for the sale or any accompanying company-specific negative catalyst.
Background
The article is an SEC Form 4 insider transaction disclosure for Amphastar Pharmaceuticals, Inc.
Ticker impact
Amphastar director Richard K Prins filed a Form 4 selling 7,973 shares at $20.30 on 2026-08-11, totaling about $161.9K.
Likely limited near-term impact; treat as low-signal unless repeated or paired with other company-specific news.
The filing is primary-source and time-stamped, but the disclosed transaction size is modest and does not include a stated company catalyst or new operational/regulatory development.
Market effects
No clear sector read-through from a single director’s modest insider sale.
None.
None.
Counterpoint
If the director’s sales are part of a broader, repeated pattern, it could reflect liquidity needs rather than bearish fundamentals, reducing the need to overreact.
Key entities
- issuerAmphastar Pharmaceuticals, Inc.
Subject of the Form 4 insider sale by a director.
- insiderPRINS RICHARD K
Director who sold 7,973 shares at $20.30 on 2026-08-11.
